Auf dieser Seite
COCP Cocrystal Pharma, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$1,15
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,7652-Wochen-Tief
$2,0352-Wochen-Hoch
Marktkapitalisierung (MRQ)
$16M
P/E
-1.5
EPS
$-0.78
Ihre Abzeichen
52W-Spanne
$1–$2
Analystenbewertung
BUY
Kursziel
$9
P/E
-1.5
ROE
-151.4%
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
COCP Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.15
Marktkapitalisierung (MRQ)
$16M
P/E
-1.5
EPS
$-0.78
ROE
-151.4%
52W-Spanne
$1–$2
COCP Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 11. Oktober 2022 | 1-for-12 | Umgekehrt |
| 24. Januar 2018 | 1-for-30 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz·2019-12-31 → 2020-12-31
EPS$-0.782016-12-31 → 2025-12-31
Freier Cashflow$-8M2018-12-31 → 2025-12-31
Nettogewinnmarge·2018-12-31 → 2020-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | COCP | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -1.55-Jahres-Durchschnitt ≈-0.9 | ≈-0.9 | · | · | |
| P/S | 7.95-Jahres-Durchschnitt ≈101.5 | ≈101.5 | · | · | |
| K/B (MRQ) | 15.15-Jahres-Durchschnitt ≈3.6 | ≈3.6 | 2.6 | Überbewertet | |
| Price / FCF (Kurs / FCF) | -1.95-Jahres-Durchschnitt ≈-15.8 | ≈-15.8 | · | · | |
| Price / Cash Flow (Kurs / Cashflow) | -1.95-Jahres-Durchschnitt ≈-15.9 | ≈-15.9 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 2.55-Jahres-Durchschnitt ≈3.7 | ≈3.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | COCP | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| ROA | -76.2%5-Jahres-Durchschnitt ≈-60.1% | ≈-60.1% | -12.4% | Schwach | |
| ROE | -151.4%5-Jahres-Durchschnitt ≈-103.4% | ≈-103.4% | -57.6% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | COCP | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.25-Jahres-Durchschnitt ≈20.0 | ≈20.0 | 2.3 | Geringe Liquidität | |
| Quick Ratio | 3.25-Jahres-Durchschnitt ≈19.0 | ≈19.0 | 1.1 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
14.2%
Nächster Bericht
Nov 12, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 13, 2026 | $-0.23 | $-0.17 | -36.7% |
| 31. März 2026 | Mai 15, 2026 | $-0.17 | $-0.15 | -11.1% |
| 31. Dezember 2025 | $-0.17 | $-0.18 | 4.8% | |
| 30. September 2025 | $-0.19 | $-0.21 | 11.3% | |
| 30. Juni 2025 | $-0.20 | $-0.31 | 34.6% | |
| 31. März 2025 | $-0.23 | $-0.52 | 55.3% | |
| 31. Dezember 2024 | $-0.32 | $-0.54 | 40.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $2M | $7M | · | · | · | · | · | |
| R&D Expense | $5M | $13M | $15M | $12M | $9M | $6M | $4M | $5M | $6M | $102M | $47M | $4M | |
| SG&A Expense | $4M | $5M | $6M | $6M | $5M | $6M | $5M | $4M | $2M | $4M | $7M | $2M | |
| Operating Expenses | $9M | $18M | $19M | $39M | $14M | $12M | $55M | $63M | $8M | $106M | $54M | $6M | |
| Operating Income | $-9M | $-18M | $-19M | $-39M | $-14M | $-10M | $-48M | $-63M | $-8M | $-106M | $-54M | $-6M | |
| Interest Expense | · | · | $-640.0K | $2.0K | $4.0K | $8.0K | $19.0K | $58.0K | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | $-7.0K | $126.0K | $180.0K | $96.0K | |
| Other Non-op | $188.0K | $374.0K | $575.0K | $-8.0K | $36.0K | $-62.0K | $237.0K | $294.0K | $769.0K | $2M | $-11M | $6M | |
| Pretax Income | $-9M | $-19M | · | · | · | $-10M | $-48M | $-63M | $-7M | $-104M | $-65M | $-151.0K | |
| Income Tax | · | · | · | · | · | · | · | $-14M | $-7M | $-29M | $-15M | $-52.0K | |
| Net Income | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| EPS (Basic) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | $-0.16 | · | · | · | $-0.03 | $-3.18 | $-2.40 | $0.00 | |
| EPS (Diluted) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · | · | · | · | $-0.03 | $-3.30 | $-2.40 | $-0.01 | |
| Shares (Basic) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | 7,364,000 | · | 31,859 | 28,009 | 24,126,000 | 23,518,000 | 21,011,000 | 326,779,000 | |
| Shares (Diluted) | 11,290,000 | 10,174,000 | 9,651,000 | 8,143,000 | · | · | · | · | 24,126,000 | 23,533,000 | 21,011,000 | 327,753,000 | |
| EBITDA | $-9M | $-18M | · | $-39M | $-14M | $-10M | $-48M | $-63M | · | · | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $10M | $26M | $37M | $59M | $33M | $7M | $3M | $748.0K | $4M | $9M | $4M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Receivables | · | · | · | · | · | $556.0K | $644.0K | · | $1.0K | $21.0K | $32.0K | $122.0K | |
| Prepaid Expense | $328.0K | $430.0K | $2M | $2M | $568.0K | $399.0K | $169.0K | $191.0K | $105.0K | $517.0K | $441.0K | $144.0K | |
| Current Assets | $8M | $12M | $29M | $40M | $59M | $34M | $8M | $3M | $2M | $5M | $10M | $6M | |
| PP&E (Net) | $93.0K | $153.0K | $271.0K | $342.0K | $453.0K | $591.0K | $431.0K | $384.0K | $119.0K | $280.0K | $430.0K | $284.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $983.0K | $1M | $1M | $1M | $949.0K | |
| Goodwill | · | · | · | · | $19M | $19M | $19M | $65M | $65M | $65M | $65M | $65M | |
| Total Assets | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Accounts Payable | $890.0K | $2M | $1M | $614.0K | $578.0K | $657.0K | $2M | $616.0K | $494.0K | $563.0K | · | $299.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $563.0K | $3M | $693.0K | |
| Current Liabilities | $2M | $2M | $3M | $1M | $2M | $1M | $2M | $2M | $1M | $2M | $7M | $9M | |
| Capital Leases | $1M | $2M | $2M | $57.0K | $291.0K | $345.0K | $523.0K | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $14M | $20M | $50M | $65M | |
| Total Liabilities | $3M | $4M | $5M | $1M | $2M | $2M | $3M | $2M | $16M | $23M | $57M | $74M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | $50M | $65M | |
| Common Stock | $13.0K | $10.0K | $10.0K | $8.0K | $8.0K | $71.0K | $36.0K | $30.0K | $24.0K | $24.0K | $694.0K | $123.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $243M | $240M | $229M | $19M | |
| Retained Earnings | $-342M | $-333M | $-316M | $-298M | $-259M | $-245M | $-235M | $-187M | $-138M | $-137M | $-63M | $-12M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | $0 | $236.0K | |
| Stockholders' Equity | $6M | $10M | $26M | $40M | $78M | $53M | $26M | $67M | $105M | $102M | $168M | $7M | |
| Liabilities + Equity | $10M | $13M | $31M | $41M | $79M | $54M | $29M | $69M | $121M | $125M | $224M | $259M | |
| Shares Outstanding | 13,784,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 70,439,000 | 35,150,000 | 29,938,000 | 24,275,000 | 23,801,000 | 694,396,000 | 122,494 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $72.0K | $126.0K | $189.0K | $185.0K | $190.0K | $157.0K | $98.0K | $6.0K | $101.0K | $201.0K | $192.0K | $199.0K | |
| Stock-based Comp | $270.0K | $643.0K | $801.0K | $855.0K | $724.0K | $662.0K | $351.0K | $562.0K | $614.0K | $548.0K | $3M | $38.0K | |
| Deferred Tax | · | · | · | · | · | · | $-14M | $-14M | $-7M | $-29M | $-15M | $-54.0K | |
| Operating Cash Flow | $-8M | $-16M | $-15M | $-21M | $-13M | $-10M | $-2M | $-8M | $-7M | $-15M | $-10M | $-6M | |
| CapEx | $12.0K | $8.0K | $118.0K | $74.0K | $52.0K | $240.0K | $145.0K | $28.0K | $40.0K | $51.0K | $339.0K | $5.0K | |
| Investing Cash Flow | $-12.0K | $-8.0K | $-118.0K | $-74.0K | $-52.0K | $-240.0K | $-145.0K | $1M | $-40.0K | $3.0K | $-262.0K | $6M | |
| Stock Issued | $154.0K | · | $4M | · | $39M | $36M | $7M | $8M | $3M | $9M | $16M | · | |
| Net Stock Activity | $154.0K | · | · | · | $39M | $36M | $7M | $8M | · | · | · | · | |
| Financing Cash Flow | $5M | · | $4M | $-27.0K | $38M | $36M | $6M | $9M | $4M | $9M | $16M | $3M | |
| Net Change in Cash | $-3M | $-16M | $-11M | $-22M | $26M | $26M | $5M | $2M | $-3M | $-6M | $5M | $3M | |
| Free Cash Flow | $-8M | $-16M | · | $-22M | $-13M | $-10M | $-2M | $-8M | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | $-8M | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| Net Margin | · | · | · | · | · | -479.0% | -733.8% | 84565.5% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | -479.0% | -733.8% | 107982.8% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | -476.0% | -737.5% | 108489.7% | · | · | · | · | |
| ROA | -76.2% | -78.3% | · | -64.6% | -21.2% | -23.3% | -99.2% | -51.6% | · | · | · | · | |
| ROE | -151.4% | -157.5% | · | -86.8% | -17.9% | -18.8% | -99.9% | -55.2% | · | · | · | · | |
| ROIC | · | · | · | · | · | · | · | -73.7% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.8 | · | 33.0 | 38.4 | 25.0 | 3.6 | 1.9 | · | · | · | · | |
| Quick Ratio | 3.2 | 4.1 | · | 30.6 | 38.0 | 24.7 | 3.5 | 1.7 | · | · | · | · | |
| Interest Coverage | · | · | · | -19414.5 | -3555.2 | -1198.2 | · | -1084.9 | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | 0.1 | -0.0 | · | · | · | · | |
| Receivables Turnover | · | · | · | · | · | 3.4 | 20.4 | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.46 | $0.94 | · | $4.86 | $0.80 | $0.75 | $0.73 | $2.23 | · | · | · | · | |
| Cash Flow / Share | $-0.73 | $-1.62 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.51 | $0.97 | · | $4.57 | $0.60 | $0.47 | $0.21 | $0.09 | · | · | · | · | |
| EPS (TTM) | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · | · | $-0.07 | $0.03 | $-0.03 | $-3.30 | $-2.40 | $-0.01 |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $2M | $2M | $2M | $2M | $7M | $78.0K | $78.0K | $78.0K | · | · | |
| Net Income TTM | $-9M | $-18M | $-18M | $-39M | $-14M | $-10M | $-48M | $-49M | $-613.0K | $-75M | $-50M | $-99.0K | |
| Market Cap | $14M | $21M | · | $16M | $760M | $1.15B | $211M | $1.29B | · | · | · | · | |
| P/E | -1.3 | -1.2 | -0.9 | -0.4 | · | · | -85.7 | 1440.0 | -2400.0 | -42.5 | -133.5 | -15120.0 | |
| P/S | 6.8 | 10.3 | · | 8.0 | 380.9 | 570.8 | 32.1 | 16581.0 | · | · | · | · | |
| P/B | 2.1 | 2.2 | · | 0.4 | 9.8 | 21.9 | 8.2 | 19.3 | · | · | · | · | |
| P / Tangible Book | 2.1 | 2.2 | 0.7 | 0.4 | 13.0 | 34.4 | · | · | · | · | · | · | |
| P / Cash Flow | -1.6 | -1.2 | · | -0.7 | -59.8 | -116.9 | -134.9 | -156.0 | · | · | · | · | |
| P / FCF | -1.6 | -1.2 | · | -0.7 | -59.5 | -114.2 | -123.5 | -155.5 | · | · | · | · | |
| Earnings Yield | -79.6% | -85.2% | -108.7% | -244.6% | · | · | -1.2% | 0.07% | -0.04% | -2.4% | -0.75% | -0.01% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $105.0K | $225.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $2M | $1M | $2M | $954.0K | $1M | $1M | $2M | $3M | $4M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | |
| SG&A Expense | $1M | $1M | $862.0K | $1M | $986.0K | $981.0K | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $2M | |
| Operating Expenses | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $5M | $5M | $4M | $5M | $4M | $4M | $5M | $5M | $6M | |
| Operating Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $-220.0K | · | $-320.0K | $-140.0K | · | $0 | $1.0K | |
| Other Non-op | $20.0K | $57.0K | $55.0K | $40.0K | $53.0K | $40.0K | $-36.0K | $103.0K | $105.0K | $202.0K | $202.0K | $278.0K | $173.0K | $-78.0K | $1.0K | $-6.0K | |
| Income Tax | $0 | $0 | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-5M | $-5M | $-4M | $-4M | $-4M | $-4M | $-5M | $-5M | $-6M | |
| EPS (Basic) | $-0.23 | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | $-0.70 | |
| EPS (Diluted) | $-0.23 | $-0.17 | $-0.16 | $-0.19 | $-0.20 | $-0.23 | $-0.31 | $-0.49 | $-0.53 | $-0.39 | $-0.41 | $-0.41 | $-0.41 | $-0.64 | $-0.54 | $-0.70 | |
| Shares (Basic) | 13,788,000 | 13,786,000 | · | 10,991,000 | 10,174,000 | 10,174,000 | · | 10,174,000 | 10,174,000 | 10,174,000 | · | 10,153,000 | 10,065,000 | 8,143,000 | · | 8,143,000 | |
| Shares (Diluted) | 13,788,000 | 13,786,000 | · | 10,991,000 | 10,174,000 | 10,174,000 | · | 10,174,000 | 10,174,000 | 10,174,000 | · | 10,153,000 | 10,065,000 | 8,143,000 | · | 8,143,000 | |
| EBITDA | $-3M | $-2M | · | $-2M | $-2M | $-2M | · | $-5M | $-5M | $-4M | · | $-4M | · | $-5M | · | $-6M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $7M | $8M | $5M | $7M | $10M | $13M | $18M | $22M | $26M | $30M | $32M | $34M | $37M | $42M | |
| Prepaid Expense | $256.0K | $418.0K | $328.0K | $465.0K | $282.0K | $385.0K | $430.0K | $509.0K | $365.0K | $2M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Current Assets | $3M | $6M | $8M | $9M | $7M | $9M | $12M | $14M | $20M | $24M | $29M | $32M | $36M | $37M | $40M | $45M | |
| PP&E (Net) | $69.0K | $81.0K | $93.0K | $106.0K | $107.0K | $127.0K | $153.0K | $181.0K | $211.0K | $244.0K | $271.0K | $252.0K | $305.0K | $338.0K | $342.0K | $378.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | · | $2M | $2M | |
| Total Assets | $5M | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | |
| Accounts Payable | $2M | $1M | $890.0K | $745.0K | $856.0K | $808.0K | $2M | $859.0K | $2M | $1M | $1M | $568.0K | $1M | $3M | $614.0K | $897.0K | |
| Current Liabilities | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $2M | $3M | $1M | $2M | |
| Capital Leases | $989.0K | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | · | $10.0K | $27.0K | $57.0K | $119.0K | |
| Total Liabilities | $4M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $2M | $2M | $3M | $1M | $2M | |
| Common Stock | $13.0K | $13.0K | $13.0K | $13.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $10.0K | $8.0K | $8.0K | $8.0K | |
| Retained Earnings | $-348M | $-345M | $-342M | $-340M | $-338M | $-336M | $-333M | $-330M | $-325M | $-320M | $-316M | $-311M | $-307M | $-303M | $-298M | $-293M | |
| Stockholders' Equity | $1M | $4M | $6M | $8M | $5M | $7M | $10M | $13M | $17M | $23M | $26M | $31M | $35M | $35M | $40M | $44M | |
| Liabilities + Equity | $5M | $7M | $10M | $10M | $9M | $11M | $13M | $16M | $22M | $27M | $31M | $33M | $36M | $38M | $41M | $46M | |
| Shares Outstanding | 13,789,000 | 13,787,000 | 13,784,000 | 13,041,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 10,174,000 | 8,143,000 | 8,143,000 | 8,143,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12.0K | $12.0K | $13.0K | $13.0K | $21.0K | $25.0K | $28.0K | $30.0K | $33.0K | $35.0K | $40.0K | $53.0K | $47.0K | $49.0K | $48.0K | $47.0K | |
| Stock-based Comp | $92.0K | $84.0K | $56.0K | $48.0K | $84.0K | $82.0K | $85.0K | $253.0K | $148.0K | $157.0K | $158.0K | $173.0K | $179.0K | $291.0K | $159.0K | $216.0K | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-1M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-6M | $-3M | $-5M | $-9M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | $0 | $8.0K | $59.0K | $0 | $14.0K | $45.0K | $12.0K | · | |
| Investing Cash Flow | · | · | $0 | · | · | · | $0 | $0 | $0 | $-8.0K | $-59.0K | $0 | $-14.0K | $-45.0K | $-12.0K | · | |
| Stock Issued | · | · | $0 | · | · | · | · | · | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | · | · | $1M | · | · | · | · | · | · | · | $0 | $0 | $4M | $-7.0K | $-7.0K | $-7.0K | |
| Net Change in Cash | $-3M | $-2M | $-704.0K | $3M | $-2M | $-3M | $-3M | $-5M | $-4M | $-5M | $-3M | $-3M | $-2M | $-3M | $-5M | $-9M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | $-3M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -3032.4% | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -3013.3% | -1021.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -3032.4% | -1047.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -48.1% | -25.4% | · | -15.4% | -13.7% | -12.4% | · | -20.2% | -18.5% | -12.3% | · | -10.6% | · | -9.2% | · | -8.9% | |
| ROE | -99.2% | -40.3% | · | -20.1% | -18.1% | -15.4% | · | -22.8% | -20.5% | -13.8% | · | -11.2% | · | -9.6% | · | -9.1% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 2.7 | · | 5.8 | 3.7 | 4.6 | · | 7.3 | 7.4 | 10.3 | · | 16.7 | · | 11.8 | · | 27.7 | |
| Quick Ratio | 0.8 | 2.1 | · | 5.1 | 2.6 | 3.6 | · | 6.7 | 6.8 | 9.2 | · | 15.5 | · | 10.8 | · | 26.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 18.9 | · | 13.9 | · | · | · | -5694.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.08 | $0.30 | · | $0.59 | $0.52 | $0.72 | · | $1.25 | $1.71 | $2.22 | · | $3.02 | · | $4.26 | · | $5.39 | |
| Revenue / Share | $0.01 | $0.02 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.17 | · | · | · | $-0.29 | · | · | · | $-0.44 | · | · | · | · | · | · | |
| Cash / Share | $0.16 | $0.34 | · | $0.59 | $0.47 | $0.68 | · | $1.28 | $1.78 | $2.15 | · | $2.92 | · | $4.17 | · | $5.16 | |
| EPS (TTM) | $-0.75 | $-0.72 | · | $-0.93 | $-1.23 | $-1.56 | · | $-1.82 | $-1.74 | $-1.62 | · | $-2.00 | $-2.29 | $-4.88 | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Net Income TTM | $-10M | $-9M | · | $-10M | $-13M | $-16M | · | $-19M | $-18M | $-17M | · | $-18M | $-20M | $-40M | · | $-38M | |
| Market Cap | $14M | $14M | · | $16M | $15M | $14M | · | $18M | $24M | $14M | · | $19M | · | $16M | · | $28M | |
| P/E | -1.4 | -1.4 | · | -1.3 | -1.2 | -0.9 | · | -1.0 | -1.3 | -0.9 | · | -0.9 | -1.0 | -0.4 | · | · | |
| P/S | · | · | · | 8.1 | 7.5 | 7.2 | · | 8.9 | 11.8 | 7.1 | · | 9.4 | · | 8.0 | · | 14.1 | |
| P/B | 13.9 | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | · | 0.5 | · | 0.6 | |
| P / Tangible Book | 13.9 | 3.4 | · | 2.1 | 2.8 | 2.0 | · | 1.4 | 1.4 | 0.6 | · | 0.6 | 0.7 | 0.5 | · | 0.6 | |
| P / Cash Flow | · | -6.0 | · | · | · | -4.9 | · | · | · | -3.2 | · | · | · | -5.2 | · | · | |
| Earnings Yield | -71.4% | -71.3% | · | -74.4% | -82.5% | -109.9% | · | -103.4% | -74.7% | -115.7% | · | -106.9% | -95.8% | -245.2% | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Nettoergebnis | $-9M | $-18M | $-18M | $-39M | $-14M |
| Verwässerte EPS | $-0.78 | $-1.72 | $-1.87 | $-4.77 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.7 | 4.8 | · | 33.0 | 38.4 |
| Quick Ratio | 3.2 | 4.1 | · | 30.6 | 38.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-8M | $-16M | · | $-22M | $-13M |
Institutionelle Eigentümer (13F) 28 Einreicher · $1.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
28
Gehaltener Wert
$1.4M
Neue Positionen
6
Geschlossene Positionen
6
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 6 (+2 vs. Vorquartal) | 6 (+3 vs. Vorquartal) | 3 (-3 vs. Vorquartal) | 7 (+3 vs. Vorquartal) | +336K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $376.139 | 358.228 | 26,77% | Aktien |
| VANGUARD GROUP INC | $258.444 | 263.987 | 18,40% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $188.609 | 179.628 | 13,43% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $184.148 | 175.379 | 13,11% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $80.034 | 76.208 | 5,70% | Aktien |
| BlackRock, Inc. | $77.433 | 73.746 | 5,51% | Aktien |
| CITADEL ADVISORS LLC | $47.374 | 45.118 | 3,37% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $33.480 | 31.886 | 2,38% | Aktien |
| XTX Topco Ltd | $30.809 | 29.342 | 2,19% | Aktien |
| JANE STREET GROUP, LLC | $27.049 | 25.761 | 1,93% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $25.217 | 24.016 | 1,80% | Aktien |
| STATE STREET CORP | $21.570 | 20.543 | 1,54% | Aktien |
| Parallel Advisors, LLC | $13.197 | 12.569 | 0,94% | Aktien |
| NORTHERN TRUST CORP | $12.517 | 11.921 | 0,89% | Aktien |
| Ground Swell Capital, LLC | $11.290 | 10.752 | 0,80% | Aktien |
| WELLS FARGO & COMPANY/MN | $6.570 | 6.257 | 0,47% | Aktien |
| UBS Group AG | $4.340 | 4.133 | 0,31% | Aktien |
| Tower Research Capital LLC (TRC) | $4.183 | 3.984 | 0,30% | Aktien |
| MORGAN STANLEY | $915 | 871 | 0,07% | Aktien |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $858 | 817 | 0,06% | Aktien |
| Clean Yield Group | $439 | 418 | 0,03% | Aktien |
| NVWM, LLC | $88 | 84 | 0,01% | Aktien |
| BARCLAYS PLC | $44 | 42 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $35 | 33 | 0,00% | Aktien |
| HRT FINANCIAL LP | $21 | 20.336 | 0,00% | Aktien |
| VIMA LLC | $18 | 17 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $0 | 9 | 0,00% | Aktien |
| Motiv8 Investments LLC | $0 | 42 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Phillip Frost, M.D., Frost Gamma Investments Trust ×6 Einreichungen | 7. August 2026 | 13,90% | Änderung | Passive Anlage | SEC |
| OPKO HEALTH, INC., FROST PHILLIP MD ET AL, Frost Gamma Investments Trust, Rubin Steven D ×5 Einreichungen | 7. August 2026 | 29,60% | Erste Einreichung | Passive Anlage | SEC |
| FiveT Investment Management Ltd, FiveT Capital AG | 25. Mai 2021 | · | Erste Einreichung | · | SEC |
| Raymond F. Schinazi, Phillip Frost, M.D., Frost Gamma Investments Trust, Gary Wilcox, Roger Kornberg, Steven D. Rubin ×3 Einreichungen | 19. März 2019 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 18 Insider · 9 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| James Sapirstein | Chief Executive Officer | 3. Juni 2026 A | · | 0 | 0 | $0 |
| Sam Lee | President and Co-CEO | 9. Januar 2026 A | 76.355 | 0 | 0 | $0 |
| James Joseph Martin | Co-CEO and CFO | 9. Januar 2026 A | 44.167 | 0 | 0 | $0 |
| Gary Wilcox | Chief Executive Officer | 22. Juni 2020 A | 16.948.605 | 0 | 0 | $0 |
| Jeffery A. Meckler | CHIEF EXECUTIVE OFFICER | 15. März 2016 P | 657.161 | 0 | 0 | $0 |
| Curtis Dale | INTERIM CFO | 24. November 2015 A | · | 0 | 0 | $0 |
| Gerald A Mcguire | CHIEF FINANCIAL OFFICER | 13. April 2015 A | · | 0 | 0 | $0 |
| Douglas L Mayers | CHIEF MEDICAL OFFICER | 1. Oktober 2015 A | · | 0 | 0 | $0 |
| Walt Addison Linscott | GENERAL COUNSEL AND SECRETARY | 21. Juli 2015 A | · | 0 | 0 | $0 |
| Phillip Frost, M.D. | Direktor | 5. August 2026 P | 1.993.551 | 11 | 0 | $300.525 |
| Anthony J Japour | Direktor | 9. Januar 2026 A | 14.924 | 0 | 0 | $0 |
| Roger D. Kornberg | Direktor | 9. Januar 2026 A | 28.109 | 0 | 0 | $0 |
| Steven D Rubin | Direktor | 9. Januar 2026 A | 2.660.242 | 0 | 0 | $0 |
| Richard C Pfenniger JR | Direktor | 9. Januar 2026 A | 31.400 | 0 | 0 | $0 |
| Fred Hassan | Direktor | 9. Januar 2026 A | 1.383.009 | 0 | 0 | $0 |
| David S Block | Direktor | 21. September 2018 A | 168.696 | 0 | 0 | $0 |
| HSIAO JANE PH D | Direktor | 21. September 2018 A | 3.435.294 | 0 | 0 | $0 |
| Raymond F Schinazi | 10%-Eigentümer | 4. Mai 2021 S | 7.674.960 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
COCP Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 7 Analysten
KAUF
Median-Ziel
$9.00
+686,0%
2 28,6%
Starker Kauf
4 57,1%
Kauf
1 14,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
2 Analysten · 2026-09-29Mittelwert-Ziel $9.00 +686,0%
← Unter allen Zielen
Aktueller Preis $1.15
Tief$8.00
Mittelwert$9.00
Hoch$10.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026